Connection

NANCY DUGAL PERRIER to Aged, 80 and over

This is a "connection" page, showing publications NANCY DUGAL PERRIER has written about Aged, 80 and over.
Connection Strength

0.716
  1. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma. World J Surg. 2020 02; 44(2):544-551.
    View in: PubMed
    Score: 0.046
  2. Understanding Thyroidectomy Cost Variations Among National Cancer Institute-Designated Cancer Centers. World J Surg. 2020 02; 44(2):385-392.
    View in: PubMed
    Score: 0.046
  3. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol. 2016 09; 23(9):2889-97.
    View in: PubMed
    Score: 0.035
  4. Adrenal metastectomy is safe in selected patients. World J Surg. 2014 Jun; 38(6):1336-42.
    View in: PubMed
    Score: 0.031
  5. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg. 2013 Feb; 216(2):280-9.
    View in: PubMed
    Score: 0.028
  6. Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism. Endocr Pract. 2012 Jul-Aug; 18(4):450-5.
    View in: PubMed
    Score: 0.027
  7. Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. Arch Surg. 2012 Apr; 147(4):338-44.
    View in: PubMed
    Score: 0.026
  8. Common locations of parathyroid adenomas. Ann Surg Oncol. 2011 Apr; 18(4):1047-51.
    View in: PubMed
    Score: 0.024
  9. Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system. Arch Surg. 2010 Nov; 145(11):1065-8.
    View in: PubMed
    Score: 0.024
  10. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol. 2009 Nov; 16(11):3146-53.
    View in: PubMed
    Score: 0.022
  11. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery. 2009 Dec; 146(6):1116-22.
    View in: PubMed
    Score: 0.022
  12. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg. 2008 May; 206(5):888-95; discussion 895-6.
    View in: PubMed
    Score: 0.020
  13. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007 Jul-Aug; 13(4):338-44.
    View in: PubMed
    Score: 0.019
  14. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006 Dec; 140(6):932-40; discussion 940-1.
    View in: PubMed
    Score: 0.018
  15. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg. 2006 May; 30(5):665-9.
    View in: PubMed
    Score: 0.018
  16. Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. Surgery. 2006 Apr; 139(4):527-34.
    View in: PubMed
    Score: 0.017
  17. Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol. 2005 Mar; 12(3):260-6.
    View in: PubMed
    Score: 0.016
  18. Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid. 2004 Oct; 14(10):806-12.
    View in: PubMed
    Score: 0.016
  19. Is there a racial difference in presentation of primary hyperparathyroidism? Am Surg. 2004 Jun; 70(6):504-6.
    View in: PubMed
    Score: 0.015
  20. HER2 expression in thyroid tumors. Am Surg. 2003 Dec; 69(12):1100-3.
    View in: PubMed
    Score: 0.015
  21. Experienced scintigraphers contribute to success of minimally invasive parathyroidectomy by skilled endocrine surgeons. Am Surg. 2003 Jun; 69(6):478-83; discussion 483-4.
    View in: PubMed
    Score: 0.014
  22. Effect of massage technique on sentinel lymph node mapping for cancer of the breast. Am Surg. 2003 Jun; 69(6):520-2.
    View in: PubMed
    Score: 0.014
  23. Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism. World J Surg. 2002 Aug; 26(8):907-13.
    View in: PubMed
    Score: 0.013
  24. Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases. Surgery. 2019 03; 165(3):637-643.
    View in: PubMed
    Score: 0.010
  25. Tumor Size and Presence of Metastatic Disease at Diagnosis are Associated with Disease-Specific Survival in Parathyroid Carcinoma. Ann Surg Oncol. 2018 Sep; 25(9):2535-2540.
    View in: PubMed
    Score: 0.010
  26. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol. 2018 08; 211(2):W109-W115.
    View in: PubMed
    Score: 0.010
  27. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol. 2018 May; 25(5):1395-1402.
    View in: PubMed
    Score: 0.010
  28. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma. Ann Surg Oncol. 2018 Mar; 25(3):801-807.
    View in: PubMed
    Score: 0.010
  29. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab. 2017 08 01; 102(8):2807-2813.
    View in: PubMed
    Score: 0.010
  30. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY). 2017 02; 42(2):577-584.
    View in: PubMed
    Score: 0.009
  31. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid. 2016 11; 26(11):1553-1562.
    View in: PubMed
    Score: 0.009
  32. An immunohistochemical survey for neuroendocrine cells in regional pancreatic lymph nodes: a plausible explanation for primary nodal gastrinomas? Mayo Clinic Pancreatic Surgery Group. Surgery. 1995 Dec; 118(6):957-65; discussion 965-6.
    View in: PubMed
    Score: 0.009
  33. Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015 Nov; 22(12):3990-5.
    View in: PubMed
    Score: 0.008
  34. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid. 2014 Jul; 24(7):1096-106.
    View in: PubMed
    Score: 0.008
  35. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg. 2014 Jun; 38(6):1318-27.
    View in: PubMed
    Score: 0.008
  36. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc. 2013 Nov; 27(11):4026-32.
    View in: PubMed
    Score: 0.007
  37. The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? J Am Coll Surg. 2013 Jul; 217(1):81-8; discussion 88-9.
    View in: PubMed
    Score: 0.007
  38. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology. 2012 Sep; 264(3):789-95.
    View in: PubMed
    Score: 0.007
  39. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer. 2012 Jun 01; 118(11):2804-12.
    View in: PubMed
    Score: 0.006
  40. Imaging characteristics of hyperfunctioning parathyroid adenomas using multiphase multidectector computed tomography: a quantitative and qualitative approach. J Comput Assist Tomogr. 2011 Sep-Oct; 35(5):560-7.
    View in: PubMed
    Score: 0.006
  41. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol. 2012 Jan; 67(1):38-46.
    View in: PubMed
    Score: 0.006
  42. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25.
    View in: PubMed
    Score: 0.006
  43. Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. Surgery. 2009 Dec; 146(6):1063-72.
    View in: PubMed
    Score: 0.006
  44. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J Int Neuropsychol Soc. 2009 Nov; 15(6):1002-11.
    View in: PubMed
    Score: 0.006
  45. Carcinoid tumors of the duodenum. Surgery. 2005 Dec; 138(6):971-7; discussion 977-8.
    View in: PubMed
    Score: 0.004
  46. Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomy. Clin Nucl Med. 2003 Dec; 28(12):955-60.
    View in: PubMed
    Score: 0.004
  47. Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. Am Surg. 2003 Sep; 69(9):757-62; discussion 762.
    View in: PubMed
    Score: 0.004
  48. Differing histologic findings after bilateral and focused parathyroidectomy. J Am Coll Surg. 2003 Apr; 196(4):535-40.
    View in: PubMed
    Score: 0.004
  49. Positron emission mammography: initial clinical results. Ann Surg Oncol. 2003 Jan-Feb; 10(1):86-91.
    View in: PubMed
    Score: 0.003
  50. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg. 1999 Jul; 134(7):699-704; discussion 704-5.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.